Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Abstract Text:

Brian J Dewar,Olivia S Gardner,Ching-Shih Chen,H Shelton Earp,James M Samet,Lee M Graves,Brian J Dewar,Olivia S Gardner,Ching-Shih Chen,H Shelton Earp,James M Samet,Lee M Graves,

Thiazolidinediones (TZDs) are synthetic ligands for the peroxisome proliferator-activated receptor gamma (PPARgamma) but also elicit PPARgamma-independent effects, most notably activation of mitogen-activated protein kinases (MAPKs). Ciglitazone rapidly activates extracellular signal-regulated kinase (Erk) MAPK, an event requiring c-Src kinase-dependent epidermal growth factor receptor (EGFR) transactivation, whereas troglitazone only weakly activates Erk and does not induce EGFR transactivation; the mechanism underlying this difference remains unclear. In this study, both ciglitazone and troglitazone increased Src activation. Similar effects were observed with Delta2-derivatives of each TZD, compounds that bind PPARgamma but do not lead to its activation, further indicating a PPARgamma-independent mechanism. Neither EGFR kinase nor Pyk2 inhibition prevented Src activation; however, inhibition of Src kinase activity prevented Pyk2 activation. Intracellular calcium chelation blocks TZD-induced Pyk2 activation; here, Src activation by both TZDs and ciglitazone-induced EGFR transactivation were prevented by calcium chelation. Accordingly, both TZDs increased calcium concentrations from intracellular stores; however, only ciglitazone produced a secondary calcium influx in the presence of extracellular calcium. Removal of extracellular calcium or inhibition of capacitative calcium entry by 2-APB prevented ciglitazone-induced EGFR transactivation and Erk activation but did not affect upstream kinase signaling pathways. These results demonstrate that upstream kinases (i.e., Src and Pyk2) are required but not sufficient for EGFR transactivation by TZDs. Moreover, influx of extracellular calcium through capacitative calcium entry may be an unrecognized component that provides a mechanism for the differential induction of EGFR transactivation by these compounds.

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Publishing Authors By Initials

BJ Dewar,OS Gardner,CS Chen,HS Earp,JM Samet,LM Graves,BJ Dewar,OS Gardner,CS Chen,HS Earp,JM Samet,LM Graves,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Molecular pharmacology

VOLUME: 72

Page Numbers: 1146-56

Journal Abbreviation: Mol. Pharmacol.

ISSN: 0026-895X

DAY: 8

MONTH: 08

YEAR: 2007

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 35623

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.

AFFILIATION: Curriculum in Toxicology , University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mol Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones Related Publications

• A manual for developing countries.
• Accident prevention in pediatric nursing.
• Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor.
• Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.
• Analytical performance of an ultrasonic particle focusing flow cytometer.
• Antepartum fetal surveillance and timing of delivery in the pregnancy complicated by diabetes mellitus.
• CONTACT-ILLUMINATION IN THE EXAMINATION OF THE CORNEA AND ANTERIOR PART OF THE EYE.
• Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.
• Characterizing the chromosomes of the platypus (Ornithorhynchus anatinus).
• Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
• Epileptic variants often mistaken for the psychoneuroses; differential diagnosis and treatment.
• Essential hypertension.
• Evaluation of a green laser pointer for flow cytometry.
• Factors influencing indirect speech and language therapy interventions for adults with learning disabilities: the perceptions of carers and therapists.
• Fibroblast apoptosis induced by Porphyromonas gingivalis is stimulated by a gingipain and caspase-independent pathway that involves apoptosis-inducing factor.
• Genetic identity of YOY bluefin tuna from the eastern and western Atlantic spawning areas.
• Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family.
• Hyperadrenocorticism: treating dogs.
• Malarial parasites as geographical markers in migratory birds?
• Management of catheter drainage.
• Origin and evolution of spermatogenesis genes on the human sex chromosomes.
• Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia.
• Prepartum milking effects on parlour behaviour, endocrine and immune responses in Holstein heifers.
• Reproduction of Blue-black Grassquits in central Brazil.
• Sex determination in platypus and echidna: autosomal location of SOX3 confirms the absence of SRY from monotremes.
• The treatment of ureteral colic and ureteral calculus by thoracolumbar sympathetic block; preliminary report.
• Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme.
• Vesicovaginal fistula and its management; with a description of an intravesical operation for certain difficult cases.
• Wegener granulomatosis.
• What is your diagnosis? Pectus excavatum.